Indeed, glycolytic flux was efficiently engaged in NK cells from neuroblastoma patients with unexpectedly higher basal glycolysis and glycolytic capacity in response to IL2 compared to pediatric controls. The gene discussed is IL2; the disease is neuroblastoma.